Temperature control for patients with sepsis
Part of Infections, Injuries & trauma clinical trials.
This trial tests whether actively warming a cool, sedated intensive-care patient with sepsis helps recovery. Sepsis is a life-threatening reaction to infection that can make body temperature drop, and this study aims to see if warming can improve outcomes.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must have a diagnosis of sepsis, which is a severe response to an infection.
- You must be on a breathing machine (intubated) and given medicine to keep you sedated.
- Your body temperature must stay below 38.3°C (101°F).
- You cannot have certain immune-system conditions, like HIV or hepatitis B or C.
- You cannot be taking medications that weaken the immune system, such as steroids (more than 300 mg hydrocortisone per day), tacrolimus, or cyclophosphamide.
- You cannot have conditions that make warming unsafe, like recent heart attack, stroke, spinal cord injury, or pregnancy.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial is building a tool to predict sepsis, a life-threatening response to infection, in intensive care patients. It may help doctors act faster to prevent complications.
This study looks at a type of immune cell called 'memory CD8+ T cells' in patients with sepsis, a life-threatening response to infection. The goal is to see if these cells are linked to how severe the sepsis is and the risk of dying. This may help doctors better predict outcomes for people with sepsis.
This trial is looking for patients who have an infection and are showing early signs of getting sicker, like a high warning score. It aims to find out if doctors can identify those at risk of sepsis sooner so they can start treatment earlier.
This trial tests if cooling the body (hypothermia) or keeping normal body temperature (normothermia) after emergency heart-lung support (ECMO) improves survival in adults who had a cardiac arrest outside the hospital.
This trial studies a quick set of tests to figure out whether a person with severe infection (sepsis) will respond to corticosteroids like hydrocortisone. The goal is to guide treatment sooner and avoid ineffective care.
This trial tests a special way to monitor tiny blood vessels (microcirculation) in patients with sepsis. The goal is to see if early treatment based on these readings can help improve recovery.
Hear when a new Sepsis trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.